Search for: "DANIEL A OUELLETTE"
Results 1 - 20
of 65
Sort by Relevance
|
Sort by Date
1 Dec 2021, 2:00 am
Lisa Larrimore Ouellette (Stanford Law School), Michael Abramowicz (George Washington University), Daniel J. [read post]
1 Nov 2021, 11:53 am
Thomas, Cases and Materials on Patent Law (West Academic 2019) Daniel H. [read post]
13 Aug 2020, 8:09 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceIn this blog post series, we have written about the importance of ensuring an adequate supply of diagnostic testing for COVID-19, and about the challenges the United States has faced so far on this front. [read post]
30 Jul 2020, 3:39 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
12 May 2020, 7:49 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceThe antiviral drug remdesivir, developed by California-based biopharmaceutical company Gilead Sciences in collaboration with government scientists, has emerged as the new standard of care for COVID-19 patients. [read post]
24 Apr 2020, 6:58 am
As Daniel Hemel and Lisa Ouellette have written, “[g]overnments can offer strong incentives to drug makers while ensuring affordability by committing to patent buyouts for effective treatments. [read post]
8 Apr 2020, 3:37 pm
Daniel Hemel is an assistant professor at the University of Chicago Law School and Lisa Larrimore Ouellette is an associate professor at Stanford Law School. [read post]
8 Apr 2020, 9:18 am
Daniel Hemel on the Role of the Private Sector in Battling COVID-19 willcanderson Wed, 04/08/2020 - 11:18 Read more about Daniel Hemel on the Role of the Private Sector in Battling COVID-19 The New York Times Daniel Hemel Lisa Larrimore Ouellette COVID-19 Pharmaceutical Profits and Public Health Are Not Incompatible [read post]
5 Mar 2020, 5:08 pm
Lisa Larrimore Ouellette is an Associate Professor at Stanford Law School. [read post]
5 Mar 2020, 5:15 am
Daniel Hemel and Lisa Larrimore Ouellette suggested that the government award a "large cash prize for any firm that develops a successful coronavirus vaccine". [read post]
12 Jan 2020, 6:00 pm
Lisa Larrimore Ouellette and Andrew Tutt: How Do Patent Incentives Affect University Researchers? [read post]
11 Apr 2019, 5:32 am
Instead, after Harry’s ousting, Harry’s brother Daniel allegedly raided the account and bargained to swap information from Harry’s account with Hall for mutual benefit. [read post]
6 Apr 2019, 2:33 pm
Ouellette (@PatentScholar) April 6, 2019A compelling new project from Lisa Ouellette (@PatentScholar) and Daniel @DanielJHemel argues that the U.S. opioid epidemic reflects a failure of innovation institutions. [read post]
5 Mar 2019, 3:30 am
Daniel J. [read post]
3 Sep 2018, 3:30 am
Daniel J. [read post]
17 Jul 2018, 3:30 am
Daniel J. [read post]
9 Mar 2018, 12:54 pm
To give one example, in their recent article, Bayh-Dole Without Borders, Lisa Larrimore Ouellette and Daniel Hemel observe that an under-appreciated feature of making federal funding for research work as an economic policy is ensuring that U.S. companies are able to protect the results of that federally-funded research abroad. [read post]
28 Feb 2018, 3:30 am
Graff Zivin, Danielle Li & Bhaven N. [read post]
6 Jun 2017, 7:37 am
(Professors Lisa Ouellette and Daniel Hemel addressed it in a blog entry cross-posted at Written Description and Whatever Source Derived. [read post]
31 May 2017, 4:59 am
” At Written Description, Daniel Hemel and Lisa Ouellette observe that the opinion “opens the door for creative contract lawyers to draft licensing agreements that severely restrict resale of patented products” and that its impact “will depend on how courts view the newfangled licensing agreements that are almost certain to follow. [read post]
